Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Parcion Private Wealth LLC Has $1.45 Million Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Lbp Am Sa
Drugmakers raised prices despite Trump deals, report finds - NBC Los Angeles
Cwm LLC Acquires 422,041 Shares of Bristol Myers Squibb Company $BMY
Cwm LLC Has $66.27 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Is Bristol Myers Squibb (BMY) Pricing Reflecting Its Recent 1 Year 22% Share Gain?
Patten Group Inc. Invests $1.04 Million in Bristol Myers Squibb Company $BMY
Is It Too Late To Reassess Bristol Myers Squibb (BMY) After Its Recent Share Price Rebound
Massachusetts Financial Services Co. MA Increases Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer
FDA Setback For Replimune Opdivo Combo Adds Uncertainty To BMY Outlook
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial
Is Bristol-Myers Squibb Company (BMY) Among the 15 Cash-Rich Dividend Stocks to Invest in Right Now
State of Alaska Department of Revenue Sells 59,405 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
State of Alaska Department of Revenue Sells 59,405 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Here are the 3 big things we're watching in the stock market this week
Bristol Myers Squibb Company $BMY Shares Sold by Robeco Institutional Asset Management B.V.
Ritholtz Wealth Management Boosts Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Sumitomo Mitsui Trust Group Inc. - Stock Observer
Should BMY's Camzyos Youth Data and T‑Cell Deal Require Action From Bristol Myers (BMY) Investors?
Bristol Myers Squibb Company $BMY Shares Sold by Cantor Fitzgerald Investment Advisors L.P.
Bartlett & CO. Wealth Management LLC Has $7.26 Million Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb (NYSE:BMY) Rating Lowered to Buy at Wall Street Zen
Assessing Bristol Myers Squibb (BMY) Valuation After Camzyos Data And T Cell Engager Collaboration News
Replimune (REPL) Stock Plunges 19% Following Second FDA Rejection of Melanoma Treatment
Replimune (REPL) Shares Plunge 19% Following Second FDA Rejection of RP1 Melanoma Treatment
Replimune (REPL) Shares Plunge 19% as FDA Issues Second Rejection for Melanoma Treatment
Douglas Lane & Associates LLC Buys 32,821 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Cancer Alliance Adds Weight To Valuation Debate
Capital Investment Advisory Services LLC Acquires 18,028 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb (NYSE:BMY) Price Target Lowered to $67.00 at Bank of America - Stock Observer
Bristol-Myers Likely to Get Desired Court in Paxton Plavix Suit
Bank of America Lowers Bristol Myers Squibb (NYSE:BMY) Price Target to $67.00
Bristol-Myers Squibb Earnings Preview: What to Expect
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid Tumors
Yousif Capital Management LLC Cuts Position in Bristol Myers Squibb Company $BMY - Markets Daily
Evotec SE (NASDAQ:EVO) Q4 2025 Earnings Call Transcript
Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks
Bristol Myers Squibb Company $BMY Shares Sold by Yousif Capital Management LLC - Stock Observer
Cantor Fitzgerald Issues Positive Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price - Stock Observer
Cantor Fitzgerald Lifts Bristol Myers (BMY) Price Target but Flags Weak Q1 Catalyst
Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026-2036) Due to the Launch of Emerging Therapies | DelveInsight
Cantor Fitzgerald Forecasts Strong Price Appreciation for Bristol Myers Squibb (NYSE:BMY) Stock
Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Recommendation of "Hold" from Brokerages - Markets Daily
Bristol Myers Squibb (NYSE:BMY) Earns Buy Rating from Guggenheim - Daily Political
Inlet Private Wealth LLC Sells 9,600 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
A Look At Bristol Myers Squibb (BMY) Valuation After US Tariff Threats Hit Pharma Stocks
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
SteelPeak Wealth LLC Purchases New Holdings in Bristol Myers Squibb Company $BMY
Is Positive Camzyos Adolescent Trial Data Altering The Investment Case For Bristol-Myers Squibb (BMY)?
Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case
Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily
Bristol Myers Squibb Company $BMY Shares Bought by FNY Investment Advisers LLC
Bristol Myers Squibb Company $BMY Shares Sold by Compagnie Lombard Odier SCmA
Aberdeen Group plc Has $183.23 Million Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company (NYSE:BMY) Receives Average Rating of "Hold" from Analysts
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease
David Elkins Sells 30,000 Shares of Bristol Myers Squibb (NYSE:BMY) Stock
Bristol Myers Squibb, Gilead Sciences to review media accounts
Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos
Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth
Head and Neck Squamous Cell Carcinoma Market Forecast to 2030 & 2035
3 Value Stocks Walking a Fine Line
20,914 Shares in Bristol Myers Squibb Company $BMY Acquired by J. Safra Sarasin Holding AG - Markets Daily
F&V Capital Management LLC Boosts Holdings in Bristol Myers Squibb Company $BMY
Janux nominates development candidate under BMS collaboration | BioWorld
Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY) - Daily Political
Three Seasons Wealth LLC Makes New $872,000 Investment in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Evolves and Expands Standing in the Ga
Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030
Bristol Myers Squibb Company $BMY Shares Bought by Nisa Investment Advisors LLC
Bristol Myers Squibb Company $BMY Shares Sold by Meyer Handelman Co.
Three Seasons Wealth LLC Buys New Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Camzyos Adolescent Trial Success Might Change The Case For Investing In Bristol-Myers Squibb (BMY)
Is Bristol Myers Squibb (BMY) Price Near US$60 Supported By Cash Flow And Earnings Models
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
Ariel Global Fund Re-Added Bristol-Myers Squibb Company (BMY) on Pipeline Strength and Attractive Valuation
Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players
Retirement Systems of Alabama Boosts Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by Retirement Systems of Alabama - Daily Political
Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC
MOAT ETF Is Down 7% in 2026. Here Is the Macro Signal That Changes Everything
Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
Paranasal Sinus Cancer Markets and Competition Outlook 2026-2030 - Precision Oncology, Minimally Invasive Surgeries, and Expanded Cancer Care Models Drive Revenue Growth
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030
Exchange Traded Concepts LLC Decreases Stock Holdings in Bristol Myers Squibb Company $BMY
1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
Northwest Wealth Management LLC Makes New $689,000 Investment in Bristol Myers Squibb Company $BMY - Stock Observer
BristolMyers News
Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence
Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist
BIRD Stock Is Trading Down After Its 582% Surge: What’s happening with Allbirds Inc?
Oil Price Outlook: Saudi Arabia’s Supply Disruptions Fuel Oil Market Volatility, Will WTI Crude Oil Go up?
Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment
US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks
Market Performance Overview: S&P 500 Rose 1.18%, Earnings Season Q1 2026, Crypto Positive Sentiment
Latest news
Show moreClose Coordination Between Israel and US on Iran Nuclear Talks Highlighted
Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure
Middle East Financial News: Saudi Arabia Steps In with $3 Billion Aid for Pakistan as UAE Demands Debt Repayment
Gold price today, April 16: XAU/USD drifts below $4,800 as the US Dollar strengthens
How is the ZA economy doing right now: What is the current rate of unemployment in South Africa?
